Blogs about: Bibf 1120
Featured Blog
Boehringer Ingelheim provide update on kinase programs
Boehringer have provided a pipeline update including information on kinase inhibitors, and announces forthcoming presentations: BIBW 2992 (Tovok) – EGFR/HER2 – Phase III study in NSCLC has… more →
Kinase News
2009 ASCO Annual Meeting Highlights: Ovarian Cancer & Select General Issues
wrote 6 months ago: The 2009 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Orlando, Florida fr … more →
Boehringer Ingelheim provide update on kinase programs
wrote 1 year ago: Boehringer have provided a pipeline update including information on kinase inhibitors, and announces … more →
Boehringer Ingelheims BIBF-1120 shows efficacy in vivo
wrote 1 year ago: Boehringer Ingelheims VEGFR/PDGFR/FGFR kinase inhbitor BIBF-1120 has been shown to demonstrate anti- … more →
Vargatef demonstrates efficacy in patients with advanced, relapsed NSCLC
wrote 1 year ago: Boehringer Ingelheim’s Angiokinase inhibitor BIBF 1120 (Vargatef) has demonstrated efficacy in … more →
